Neuroblastoma is a type of cancer that develops from immature nerve cells found in various areas of the body. The 10-year survival rate for neuroblastoma depends on several factors, including the patient's age, the stage and extent of the disease, and the type of treatment received. Generally, the 10-year survival rate for neuroblastoma is about 40% - 50%.
Risk Factors for Neuroblastoma
There are several risk factors that can increase a person's chances of developing neuroblastoma. These include age, exposure to radiation, and certain genetic conditions.
Age: Neuroblastoma is most common in children under the age of 5.
Exposure to radiation: Exposure to radiation can increase a person's risk of developing neuroblastoma.
Genetic conditions: Certain genetic conditions, such as neurofibromatosis type 1 and Li-Fraumeni syndrome, can increase a person's risk of developing neuroblastoma.
Treatment for Neuroblastoma
Treatment for neuroblastoma depends on several factors, including the stage of the disease, the extent of the disease, and the patient's age. Common treatments include chemotherapy, surgery, and radiation therapy.
Chemotherapy: Chemotherapy is a type of treatment that uses drugs to kill cancer cells. It is often used to treat neuroblastoma.
Surgery: Surgery is sometimes used to remove tumors or abnormal cells. It can also be used to insert a port for chemotherapy treatment.
Radiation therapy: Radiation therapy is a type of treatment that uses high energy x-rays to kill cancer cells. It is often used to treat neuroblastoma.
Outlook for Neuroblastoma
The outlook for neuroblastoma depends on several factors, including the stage and extent of the disease, the patient's age, and the type of treatment received. Generally, the 10-year survival rate for neuroblastoma is about 40% - 50%.